TABLE 4.

Logistic Regression of Risk Factors for 90-Day Mortality in Patients With a Diagnosis of Pneumatosis

Characteristic	Odds Ratio	95% CI	P Value
Metastatic cancer	4.78	4.23–5.40	<0.001
Lymphoma	2.39	1.95–2.94	<0.001
Liver disease	2.26	2.10–2.43	<0.001
Complicated HTN	1.91	1.73–2.10	<0.001
Other neurologic disease	1.89	1.75–2.05	<0.001
Paralysis	1.71	1.46–2.00	<0.001
Coagulopathy	1.57	1.46–1.70	<0.001
Peripheral vascular disease	1.52	1.41–1.64	<0.001
Solid tumor	1.46	1.34–1.60	<0.001
Rheumatoid arthritis/CVD	1.45	1.30–1.62	<0.001
Weight loss	1.39	1.29–1.50	<0.001
Renal failure	1.38	1.27–1.51	<0.001
Blood loss anemia	1.37	1.12–1.67	0.002
Uncomplicated diabetes	1.36	1.23–1.50	<0.001
Drug abuse	1.32	1.16–1.52	<0.001
Complicated diabetes	1.2	1.09–1.32	<0.001
Sex (male)	1.12	1.05–1.20	<0.001
CHF	1.12	1.03–1.23	0.011
Time first pneumatosis Dx	1	1.00–1.00	<0.001
Obesity	0.89	0.79–1.01	0.071
Uncomplicated HTN	0.87	0.81–0.94	<0.001
Pulmonary circulation disorders	0.84	0.76–0.94	0.002
Chronic pulmonary disease	0.71	0.65–0.77	<0.001
AIDS	0.67	0.46–0.97	0.035
Alcohol abuse	0.66	0.59–0.73	<0.001
Peptic ulcer disease	0.5	0.42–0.61	<0.001
Psychoses	0.17	0.13–0.21	<0.001
Cardiac arrhythmias	1.03	0.96–1.11	0.4
Depression	1.01	0.93–1.11	0.7
Age	1	1.00–1.00	0.4
Deficiency anemia	0.98	0.89–1.08	0.7
Valvular disease	0.97	0.88–1.08	0.6
Hypothyroidism	0.97	0.88–1.07	0.5
Pneumatosis intestinalis	0.3	0.01–18.6	0.6

CVD indicates collagen vascular disease; HTN, hypertension.